Why the study?
The molecular mechanisms underpinning arrhythmogenic right ventricular cardiomyopathy and progressive fibro-fatty replacement are largely unknown.
In silico modeling suggests that simultaneous inactivation of Wnt/β-catenin and RhoA-ROCK pathways is required for adipogenic gene expression (PPARγ) in ARVC.
Answers are grounded in this paper and cite their sources.
Mathematical model of ARVC remodeling may generate mechanistic hypotheses; leaves open experimental validation before any clinical application.
Arrhythmogenic Right Ventricular cardiomyopathy (ARVC) is an inherited cardiac muscle disease linked to genetic deficiency in components of the desmosomes. The disease is characterized by progressive fibro-fatty replacement of the right ventricle, which acts as a substrate for arrhythmias and sudden cardiac death. The molecular mechanisms underpinning ARVC are largely unknown. Here we propose a mathematical model for investigating the molecular dynamics underlying heart remodeling and the loss of cardiac myocytes identity during ARVC. Our methodology is based on three computational models: firstly, in the context of the Wnt pathway, we examined two different competition mechanisms between β-catenin and Plakoglobin (PG) and their role in the expression of adipogenic program. Secondly, we investigated the role of RhoA-ROCK pathway in ARVC pathogenesis, and thirdly we analyzed the interplay between Wnt and RhoA-ROCK pathways in the context of the ARVC phenotype. We conclude with the following remark: both Wnt/β-catenin and RhoA-ROCK pathways must be inactive for a significant increase of PPARγ expression, suggesting that a crosstalk mechanism might be responsible for mediating ARVC pathogenesis.
No takes yet. Share an insight, caveat, or question.
Parrotta et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: